Proteomics

Dataset Information

0

Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro-inflammatory tumor microenvironment in esophageal adenocarcinoma


ABSTRACT: Esophageal adenocarcinomas represent aggressive gastrointestinal malignancies, characterized by poor survival and variable responses to perioperative therapies. Our study identified a significant association between adherens junction (AJ) protein expression and treatment response to FLOT chemotherapy. We demonstrate that AJ dysregulation occurs across histological subtypes and correlates with pro-inflammatory tumor microenvironment and extracellular matrix remodeling. These findings provide a foundation which could guide treatment selection, potentially avoiding ineffective therapies while identifying patients for alternative approaches. The adenocarcinoma samples analyzed in this study were part of a larger cohort for mass spectrometry proteomic analysis that also included esophageal squamous cell carcinomas (PEC) and normal esophageal tissue. All samples from this comprehensive cohort were preprocessed together up to and including the analysis of protein expression quantification, and the complete dataset is deposited in this upload.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Esophagus

SUBMITTER: Proteomics Facility  

LAB HEAD: Alexander Quaas

PROVIDER: PXD071328 | Pride | 2026-01-06

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
3099_001.raw Raw
3099_002.raw Raw
3099_003.raw Raw
3099_004.raw Raw
3099_005.raw Raw
Items per page:
1 - 5 of 350

Similar Datasets

2025-04-11 | PXD062507 | Pride
2025-11-10 | PXD068453 | Pride
2024-05-02 | PXD047261 | Pride
2025-08-25 | PXD062319 | Pride
2025-07-07 | PXD060147 | Pride
2019-03-05 | PXD011464 | Pride
2025-05-07 | PXD058234 | Pride
2024-11-18 | PXD054145 | Pride
2024-11-18 | PXD054127 | Pride
2025-10-17 | PXD069565 | Pride